Found: 4
Select item for more details and to access through your institution.
Tretinoin synergistically enhances the antitumor effect of combined BRAF, MEK, and EGFR inhibition in BRAF<sup>V600E</sup> colorectal cancer.
- Published in:
- Cancer Science, 2024, v. 115, n. 11, p. 3740, doi. 10.1111/cas.16280
- By:
- Publication type:
- Article
Depth of response may predict clinical outcome in patients with recurrent/metastatic head and neck cancer treated with pembrolizumab-containing regimens.
- Published in:
- Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1230731
- By:
- Publication type:
- Article
Genome-wide DNA methylation status is a predictor of the efficacy of anti-EGFR antibodies in the second-line treatment of metastatic colorectal cancer: Translational research of the EPIC trial.
- Published in:
- International Journal of Colorectal Disease, 2024, v. 39, n. 1, p. 1, doi. 10.1007/s00384-024-04659-y
- By:
- Publication type:
- Article
Antibiotics May Interfere with Nivolumab Efficacy in Patients with Head and Neck Squamous Cell Carcinoma.
- Published in:
- Oncology, 2024, v. 102, n. 3, p. 252, doi. 10.1159/000533860
- By:
- Publication type:
- Article